Supporter of Dick Gephardt
Supported by HARPA Health Advanced Projects Research Agency
Notes "90% of what Pharma takes out into that long pathway to bedside fails. And so all the capital that they put into clinical trials, into applied research, is down the drain. So this whole pathway from bench to bedside is not being treated carefully." Dick Gephardt, Member of the House of Representatives 1976-2004
Updated over 3 years ago

Source Links